FDA NDC

Gattex

This name is from the loaded FDA file.

Source: FDA NDC Directory, live from openFDA. Publisher page

NDC
68875-0101
Proprietary name
Gattex
Nonproprietary name
teduglutide
Labeler
Takeda Pharmaceuticals America, Inc.
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Strength
5 mg/.5mL

Run it in Rivvi

Which 2027 plans near you dropped or restricted teduglutide?

Tier changes and new prior auth, step therapy or quantity limits, plan by plan, from the CMS Part D files.

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Try it on your own data today.

Free to start. Most teams are using it the same day.